Henning Reis

24PUBLICATIONS
85CO-AUTHORS
Molecular targetsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Instrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 11, 2025
[Molecular Tumour Boards for Urological Tumours: Hope or Disappointment?]

Nadine Therese Gaisa, Markus Eckstein, Jozefina Casuscelli

|Jul 01, 2025
Relationship Among DNA Damage Response Gene Alterations, Molecular Subtypes, and Survival Outcomes in Patients With Metastatic Bladder Cancer Treated on CALGB 90601.

Gopa Iyer, Woonyoung Choi, Bin Luo

|May 12, 2025
Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients.

Maximilian N Kinzler, Eric Metzger, Rebecca Schulz

|Dec 06, 2024
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With BRCA Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand Therapy.

Mike Wenzel, Florestan Koll, Benedikt Hoeh

|Nov 29, 2024
Unexpectedly high variability in determining tumour extent in prostatic biopsies: implications for active surveillance.

Marit Bernhardt, Leonie Weinhold, Felix Bremmer

|Apr 19, 2024
[Rare tumors and tumor types of the urinary system in the 5th edition of the WHO classification 2022].

Henning Reis, Hikmat Al-Ahmadie, Tibor Szarvas

Pageof 4

Frequent Collaborators

6 joint publications

Tibor Szarvas

5 joint publications

Maximilian N Kinzler

3 joint publications

Stefan Zeuzem

3 joint publications

Fabian Finkelmeier